Incremental prognostic value of immune cell densities beyond clinical parameters in non-small cell lung cancer

Key Points

• Immune cell densities offer limited prognostic value in predicting outcomes, indicating clinical parameters are still primary predictors.
• Specifically, the ability of immune cell densities to enhance predictions beyond clinical parameters appears minimal.
• Assessment of immune cell densities underscores an opportunity for development in methodology and focused analysis.
• These findings highlight the need for improved clinical stratification strategies, as the current reliance on clinical parameters may overlook crucial data.

Abstract